Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses

References

• Doris A, Ebmeier K, Shajahan P. Depressive illness. Lancet. 1999; 354:1369–75.
   PubMed Web of Science ®Google Scholar
• Jansson LB, Parnas J. Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?Schizophr Bull. 2007; 33:1178–200.
   PubMed Web of Science ®Google Scholar
• van Os J, Kapur S. Schizophrenia. Lancet. 2009;374:635–45.
   PubMed Web of Science ®Google Scholar
• Ebmeier KP, Donaghey C, Steele JD. Recent developments and current controversies in depression. Lancet. 2006;367:153–67.
   PubMed Web of Science ®Google Scholar
• Sartorius N. The economic and social burden of depression. J Clin Psychiatry. 2001;62(Suppl 15):8–11.
   Google Scholar
• Freedman R. Schizophrenia. N Engl J Med. 2003;349:1738–49.
   PubMed Web of Science ®Google Scholar
• Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–57.
   PubMed Web of Science ®Google Scholar
• Rush AJ, Thase ME, Dube S. Research issues in the study of difficult-to-treat depression. Biol Psychiatry. 2003;53:743–53.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Fleck MP, Turecki G. Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Ann Med. 2008;40:149–59.
   PubMed Web of Science ®Google Scholar
• Elkis H. Treatment-resistant schizophrenia. Psychiatr Clin North Am. 2007;30:511–33.
   PubMed Web of Science ®Google Scholar
• Mann JJ. The medical management of depression. N Engl J Med. 2005;353:1819–34.
   PubMed Web of Science ®Google Scholar
• George MS, Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology. 2010;35:301–16.
   PubMed Web of Science ®Google Scholar
• Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008–39.
   PubMed Web of Science ®Google Scholar
• Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry. 2008;53:555–66.
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Lancet Neurol. 2003;2:145–56.
   PubMed Web of Science ®Google Scholar
• Fregni F, Pascual-Leone A. Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS. Nat Clin Pract Neurol. 2007;3:383–93.
   PubMedGoogle Scholar
• Hallett M. Transcranial magnetic stimulation and the human brain. Nature. 2000;406:147–50.
   PubMed Web of Science ®Google Scholar
• Marangell LB, Martinez M, Jurdi RA, Zboyan H. Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr Scand. 2007;116:174–81.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Brown TL, Daskalakis ZJ. The application of transcranial magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatr Scand. 2002;105:324–40.
   PubMed Web of Science ®Google Scholar
• Iacoboni M. The role of premotor cortex in speech perception: evidence from fMRI and rTMS. J Physiol Paris. 2008;102:31–4.
   PubMed Web of Science ®Google Scholar
• Rushworth MFS, Hadland KA, Paus T, Sipila PK. Role of the human medial frontal cortex in task switching: a combined fMRI and TMS study. J Neurophysiol. 2002;87:2577–92.
   PubMed Web of Science ®Google Scholar
• Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A. A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol. 2007;118:2730–44.
   PubMed Web of Science ®Google Scholar
• Levkovitz Y, Rabany L, Harel EV, Zangen A. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study. Int J Neuropsychopharmacol. 2011;14:991–6.
   PubMed Web of Science ®Google Scholar
• Slotema CW, Blom JD, Hoek HW, Sommer IE. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)?A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71:873–84.
   PubMed Web of Science ®Google Scholar
• Blumberger DM, Fitzgerald PB, Mulsant BH, Daskalakis ZJ. Repetitive transcranial magnetic stimulation for refractory symptoms in schizophrenia. Curr Opin Psychiatry. 2010;23:85–90.
   PubMed Web of Science ®Google Scholar
• Ridding MC, Rothwell JC. Is there a future for therapeutic use of transcranial magnetic stimulation?Nat Rev Neurosci. 2007;8:559–67.
   PubMed Web of Science ®Google Scholar
• Pigot M, Loo C, Sachdev P. Repetitive transcranial magnetic stimulation as treatment for anxiety disorders. Expert Rev Neurother. 2008;8:1449–55.
   PubMedGoogle Scholar
• Xia G, Gajwani P, Muzina DJ, Kemp DE, Gao K, Ganocy SJ, et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2008;11:119–30.
   PubMed Web of Science ®Google Scholar
• Takeshita S, Kurisu K, Trop L, Arita K, Akimitsu T, Verhoeff NP. Effect of subthalamic stimulation on mood state in Parkinson's disease: evaluation of previous facts and problems. Neurosurg Rev. 2005;28: 179–86; discussion 87.
   PubMed Web of Science ®Google Scholar
• Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord. 2006;12:265–72.
   PubMed Web of Science ®Google Scholar
• Allan CL, Herrmann LL, Ebmeier KP. Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology. 2011;64:163–9.
   Google Scholar
• Fregni F, Marcolin MA, Myczkowski M, Amiaz R, Hasey G, Rumi DO, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006;9:641–54.
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Lopes M, Kaptchuk TJ, Fregni F. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis. PloS One. 2009;4:e4824.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Oxley TJ, Laird AR, Kulkarni J, Egan GF, Daskalakis ZJ. An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Res. 2006;148: 33–45.
   PubMed Web of Science ®Google Scholar
• Appleby BS, Duggan PS, Regenberg A, Rabins PV. Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years’ experience. Mov Disord. 2007;22: 1722–8.
   PubMed Web of Science ®Google Scholar
• McClintock SM, Tirmizi O, Chansard M, Husain MM. A systematic review of the neurocognitive effects of magnetic seizure therapy. Int Rev Psychiatry. 2011;23:413–23.
   PubMed Web of Science ®Google Scholar
• Kozel FA, George MS. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract. 2002;8:270–5.
   PubMedGoogle Scholar
• Schutter DJ. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med. 2010;40:1789–95.
   PubMed Web of Science ®Google Scholar
• Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002;5:73–103.
   PubMed Web of Science ®Google Scholar
• Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci. 2005;30:83–90.
   PubMed Web of Science ®Google Scholar
• Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry. 2006;67:1870–6.
   PubMed Web of Science ®Google Scholar
• Holtzheimer PE 3rd, Russo J, Avery DH. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull. 2001;35:149–69.
   PubMedGoogle Scholar
• Lam RW, Chan P, Wilkins-Ho M, Yatham LN. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry. 2008;53:621–31.
   PubMed Web of Science ®Google Scholar
• Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39:65–75.
   PubMed Web of Science ®Google Scholar
• Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry. 2003;182:480–91.
   PubMed Web of Science ®Google Scholar
• Gross M, Nakamura L, Pascual-Leone A, Fregni F. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved?A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand. 2007;116: 165–73.
   Google Scholar
• Aleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry. 2007;68:416–21.
   PubMed Web of Science ®Google Scholar
• Dlabac-de Lange JJ, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry. 2010;71:411–8.
   PubMed Web of Science ®Google Scholar
• Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res. 2009;108:11–24.
   PubMed Web of Science ®Google Scholar
• Tranulis C, Sepehry AA, Galinowski A, Stip E. Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation?A metaanalysis. Can J Psychiatry. 2008;53:577–86.
   Google Scholar
• McNamara B, Ray JL, Arthurs OJ, Boniface S. Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychol Med. 2001;31:1141–6.
   PubMed Web of Science ®Google Scholar
• Kimbrell TA, Little JT, Dunn RT, Frye MA, Greenberg BD, Wassermann EM, et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry. 1999;46:1603–13.
   PubMed Web of Science ®Google Scholar
• Loo C, Mitchell P, Sachdev P, McDarmont B, Parker G, Gandevia S. Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression. Am J Psychiatry. 1999;156:946–8.
   PubMed Web of Science ®Google Scholar
• Padberg F, Zwanzger P, Thoma H, Kathmann N, Haag C, Greenberg BD, et al. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMSI. Psychiatry Res. 1999;88:163–71.
   PubMed Web of Science ®Google Scholar
• Hoppner J, Schulz M, Irmisch G, Mau R, Schlafke D, Richter J. Antidepressant efficacy of two different rTMS procedures - High frequency over left versus low frequency over right prefrontal cortex compared with sham stimulation. Eur Arch Psychiatry Clin Neurosci. 2003;253:103–9.
   PubMed Web of Science ®Google Scholar
• Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?Am J Psychiatry. 2004;161:2163–77.
   PubMed Web of Science ®Google Scholar
• Rosenberg R. Outcome measures of antidepressive therapy. Acta Psychiatr Scand Suppl. 2000;402:41–4.
   Google Scholar
• Holtzheimer PE 3rd, Russo J, Claypoole KH, Roy-Byrne P, Avery DH. Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation. Depress Anxiety. 2004;19: 24–30.
   PubMed Web of Science ®Google Scholar
• Berlim MT, Turecki G. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry. 2007;52:46–54.
   PubMed Web of Science ®Google Scholar
• Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med. 1995;25: 247–61.
   PubMed Web of Science ®Google Scholar
• Davidson RJ, Abercrombie H, Nitschke JB, Putnam K. Regional brain function, emotion and disorders of emotion. Curr Opin Neurobiol. 1999;9:228–34.
   PubMed Web of Science ®Google Scholar
• Drevets WC. Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression. Prog Brain Res. 2000;126:413–31.
   PubMed Web of Science ®Google Scholar
• Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol. 2001;11:240–9.
   PubMed Web of Science ®Google Scholar
• Rogers MA, Kasai K, Koji M, Fukuda R, Iwanami A, Nakagome K, et al. Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence. Neurosci Res. 2004;50: 1–11.
   PubMed Web of Science ®Google Scholar
• Schutter DJ, van Honk J. A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression. J Psychiatry Neurosci. 2005;30:91–7.
   Google Scholar
• Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 1996;348:233–7.
   PubMed Web of Science ®Google Scholar
• Herbsman T, Avery D, Ramsey D, Holtzheimer P, Wadjik C, Hardaway F, et al. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry. 2009;66:509–15.
   PubMed Web of Science ®Google Scholar
• Herwig U, Padberg F, Unger J, Spitzer M, Schonfeldt-Lecuona C. Transcranial magnetic stimulation in therapy studies: examination of the reliability of “standard” coil positioning by neuronavigation. Biol Psychiatry. 2001;50:58–61.
   Google Scholar
• Daskalakis ZJ, Farzan F, Barr MS, Maller JJ, Chen R, Fitzgerald PB. Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study. Neuropsychopharmacology. 2008;33:2860–9.
   PubMed Web of Science ®Google Scholar
• Padberg F, Zwanzger P, Keck ME, Kathmann N, Mikhaiel P, Ella R, et al. Repetitive transcranial magnetic stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacology. 2002;27:638–45.
   PubMed Web of Science ®Google Scholar
• Herwig U, Fallgatter AJ, Hoppner J, Eschweiler GW, Kron M, Hajak G, et al. Antidepressant effects of augmentative transcranial magnetic stimulation: randomised multicentre trial. Br J Psychiatry. 2007;191:441–8.
   PubMed Web of Science ®Google Scholar
• Avery DH, Isenberg KE, Sampson SM, Janicak PG, Lisanby SH, Maixner DF, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry. 2008;69:441–51.
   PubMed Web of Science ®Google Scholar
• George MS, Lisanby SH, Sackeim HA. Transcranial magnetic stimulation - applications in neuropsychiatry. Arch Gen Psychiatry. 1999;56:300–11.
   PubMed Web of Science ®Google Scholar
• Garcia-Toro M, Pascual-Leone A, Romera M, Gonzalez A, Mico J, Ibarra O, et al. Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression. J Neurol Neurosurg Psychiatry. 2001;71:546–8.
   PubMed Web of Science ®Google Scholar
• Rumi DO, Gattaz WF, Rigonatti SP, Rosa MA, Fregni F, Rosa MO, et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry. 2005;57:162–6.
   PubMed Web of Science ®Google Scholar
• Downar J, Daskalakis ZJ. New targets for rTMS in depression: a review of convergent evidence. Brain Stimul.2012 Sep 7 [Epub ahead of print].
   Google Scholar
• van Honk J, Schutter DJ, Putman P, de Haan EH, d’Alfonso AA. Reductions in phenomenological, physiological and attentional indices of depressive mood after 2 Hz rTMS over the right parietal cortex in healthy human subjects. Psychiatry Res. 2003;120:95–101.
   Google Scholar
• Roth Y, Amir A, Levkovitz Y, Zangen A. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol. 2007;24:31–8.
   PubMed Web of Science ®Google Scholar
• Harel EV, Zangen A, Roth Y, Reti I, Braw Y, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study. World J Biol Psychiatry. 2011;12:119–26.
   PubMed Web of Science ®Google Scholar
• Levkovitz Y, Harel EV, Roth Y, Braw Y, Most D, Katz LN, et al. Deep transcranial magnetic stimulation over the prefrontal cortex: Evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul. 2009;2:188–200.
   PubMed Web of Science ®Google Scholar
• Slotema CW, Blom JD, de Weijer AD, Diederen KM, Goekoop R, Looijestijn J, et al. Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations?Negative results from a large randomized controlled trial. Biol Psychiatry. 2011;69:450–6.
   Google Scholar
• Murphy BP, Chung YC, Park TW, McGorry PD. Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr Res. 2006;88:5–25.
   PubMed Web of Science ®Google Scholar
• Pantelis C, Lambert TJ. Managing patients with “treatment-resistant” schizophrenia. Med J Aust. 2003;178(Suppl):S62–6.
   Google Scholar
• Edwards J, McGorry PD, Waddell FM, Harrigan SM. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr Res. 1999;40:147–58.
   PubMed Web of Science ®Google Scholar
• Hovington CL, Lepage M. Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia. Expert Rev Neurother. 2012;12:53–69.
   PubMed Web of Science ®Google Scholar
• Buchanan RW. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull. 2007;33:1013–22.
   PubMed Web of Science ®Google Scholar
• Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam’s razor. Schizophr Bull. 2010;36:359–69.
   PubMed Web of Science ®Google Scholar
• Malla AK, Norman RM, Takhar J, Manchanda R, Townsend L, Scholten D, et al. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis?J Nerv Ment Dis. 2004;192:455–63.
   PubMed Web of Science ®Google Scholar
• Dickey CC, McCarley RW, Voglmaier MM, Niznikiewicz MA, Seidman LJ, Hirayasu Y, et al. Schizotypal personality disorder and MRI abnormalities of temporal lobe gray matter. Biol Psychiatry. 1999;45: 1393–402.
   PubMed Web of Science ®Google Scholar
• Gaser C, Nenadic I, Volz HP, Buchel C, Sauer H. Neuroanatomy of ‘hearing voices’: a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia. Cereb Cortex. 2004;14:91–6.
   PubMed Web of Science ®Google Scholar
• Onitsuka T, Shenton ME, Salisbury DF, Dickey CC, Kasai K, Toner SK, et al. Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study. Am J Psychiatry. 2004;161:1603–11.
   PubMed Web of Science ®Google Scholar
• Schonfeldt-Lecuona C, Gron G, Walter H, Buchler N, Wunderlich A, Spitzer M, et al. Stereotaxic rTMS for the treatment of auditory hallucinations in schizophrenia. Neuroreport. 2004;15:1669–73.
   PubMedGoogle Scholar
• Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry. 2000;57:1033–8.
   PubMed Web of Science ®Google Scholar
• Choi JS, Kang DH, Kim JJ, Ha TH, Roh KS, Youn T, et al. Decreased caudal anterior cingulate gyrus volume and positive symptoms in schizophrenia. Psychiatry Res. 2005;139:239–47.
   PubMed Web of Science ®Google Scholar
• Korsnes MS, Hugdahl K, Nygard M, Bjornaes H. An fMRI study of auditory hallucinations in patients with epilepsy. Epilepsia. 2010;51: 610–7.
   PubMedGoogle Scholar
• Koutsouleris N, Gaser C, Jager M, Bottlender R, Frodl T, Holzinger S, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage. 2008;39:1600–12.
   PubMed Web of Science ®Google Scholar
• Quarantelli M, Larobina M, Volpe U, Amati G, Tedeschi E, Ciarmiello A, et al. Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and nondeficit schizophrenia. Neuroimage. 2002;17:373–84.
   PubMedGoogle Scholar
• Yoshida T, McCarley RW, Nakamura M, Lee K, Koo MS, Bouix S, et al. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res. 2009;113:84–94.
   PubMed Web of Science ®Google Scholar
• Brunelin J, Poulet E, Bediou B, Kallel L, Dalery J, D’Amato T, et al. Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophr Res. 2006;81:41–5.
   PubMed Web of Science ®Google Scholar
• Chibbaro G, Daniele M, Alagona G, Di Pasquale C, Cannavo M, Rapisarda V, et al. Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neurosci Lett. 2005;383:54–7.
   PubMed Web of Science ®Google Scholar
• Goyal N, Nizamie SH, Desarkar P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. J Neuropsychiatry Clin Neurosci. 2007; 19:464–7.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Herring S, Hoy K, McQueen S, Segrave R, Kulkarni J, et al. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul. 2008;1:27–32.
   PubMed Web of Science ®Google Scholar
• Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr Res. 2007;95:151–7.
   PubMed Web of Science ®Google Scholar
• Holi MM, Eronen M, Toivonen K, Toivonen P, Marttunen M, Naukkarinen H. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophr Bull. 2004;30:429–34.
   PubMed Web of Science ®Google Scholar
• Jandl M, Bittner R, Sack A, Weber B, Gunther T, Pieschl D, et al. Changes in negative symptoms and EEG in schizophrenic patients after repetitive Transcranial Magnetic Stimulation (rTMS): an open-label pilot study. J Neural Transm. 2005;112:955–67.
   PubMedGoogle Scholar
• Sachdev P, Loo C, Mitchell P, Malhi G. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry Clin Neurosci. 2005;59:354–7.
   PubMed Web of Science ®Google Scholar
• Ferreira Gonzalez I, Urrutia G, Alonso-Coello P. [Systematic reviews and meta-analysis: scientific rationale. and interpretation]. Rev Esp Cardiol. 2011;64:688–96.
   Google Scholar